期刊文献+

大肠肿瘤血管内皮生长因子的表达及其作用机制探讨 被引量:1

The Expression of VEGF in Colorectal Neoplasm and Discussion of Its Active Mechanism
下载PDF
导出
摘要 目的 :通过检测血管内皮生因子 (VEGF)的表达来明确它与大肠肿瘤临床病理因素的关系。方法 :应用免疫组织化学方法 (SABC法 ) ,采用VEGF多克隆抗体测定 55例病理证实的大肠癌标本及 17例大肠腺瘤标本中VEGF的表达。结果 :大肠癌VEGF的阳性例数为 36,表达率 ( 65% )高于大肠腺瘤 ,差别显著 (P <0 .0 5) ;发生淋巴结转移大肠癌VEGF的表达率高于未发生转移的大肠癌 ,差别显著 (P<0 .0 5) ,未发生淋巴结转移大肠癌VEGF的表达率高于大肠腺瘤 ,差别显著 (P <0 .0 5) ,结论 Objective To determine the expression of VEGF in colorectal neoplasm and its clinical significance.Methods The expression of VEGF in 55 patients with colorectal carcinoma and 17 patients with adenomas were investigated using immunohistochemical staining.Results The positive rates of VEGF colorectal cancer were significantly higher than that of adenomas ( P <0.05);VEGF in colorectal cancer were significantly correlated with lymphnode metastasis ( P <0.05);VEGF expression was significantly increased from adenomas to colorectal cancer without lymph node metastasis ( P <0.05).Conclusions Over expression of VEGF existed in colorectal neoplasm was likely to show carcinomatous change and an increased character of metastasis.
出处 《肿瘤防治杂志》 2001年第1期38-40,共3页 China Journal of Cancer Prevention and Treatment
关键词 大肠肿瘤 内皮生长因子 血管 免疫组织化学 colorectal neoplasm VEGF immunohistochemistry
  • 相关文献

参考文献1

二级参考文献1

  • 1Manfred Volm,Reet Koom?gi,Manfred Kaufmann,Jürgen Mattern,Gerd Stammler. Microvessel density, expression of proto-oncogenes, resistance-related proteins and incidence of metastases in primary ovarian carcinomas[J] 1996,Clinical &amp; Experimental Metastasis(3):209~214 被引量:1

共引文献4

同被引文献10

  • 1董佑红,伍钢,王涛,刘莉.NF-κB p50和VEGF在弥漫性大B细胞淋巴瘤组织中的表达及其临床意义[J].中华肿瘤防治杂志,2007,14(6):436-439. 被引量:12
  • 2Folkman J. Tumor Angiogenesis[J]. Adv Cancer Res, 1985,43 : 175-203. 被引量:1
  • 3Roskoski R. Vascular endothelial growth factor (VEGF) signa ling in tumor progression[J]. Crit Rev Oncol Hematol, 2007, 62(3) : 179-213. 被引量:1
  • 4Ladomery M R, Harper S J, Bates D O. Alternative splicing in angiogenesis: The vascular endothelial growth factor paradigm [J]. Cancer Lett, 2007, 249(2):121-300. 被引量:1
  • 5Cui T G, Foster R R, Bates D O, et al. Differentiated human podoeytes endogenously express an inhibitory isoform of vascular endothelial growth factor (VEGF165b) mRNA and protein[J]. Am J Physiol Renal Physiol, 2004, 286(4) :F767-F773. 被引量:1
  • 6Bates D O, Cui T G, Harper SJ. VEGF165b, et al. An inhibitory splice variant of vascular endothelial growth factor, is down regulated in renal cell carcinoma[J]. Cancer Res, 2002, 62(14) : 4123-4131. 被引量:1
  • 7Varey A H, Rennel E S, Bates D O, et al. VEGF165b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro and antiangiogenic VEGF-A isoforms has implications for therapy[J]. BrJ Cancer, 2008, 98(8):1366-1379. 被引量:1
  • 8Pritchard-Jones R, Dunn D B A, Bates D O, et al. Expression of VEGFxxxb, the inhibitory isoforms of VEGF, in malignant melanoma[J]. Br J Cancer, 2007, 97(2) :223-230. 被引量:1
  • 9Rennel E S, Hamdollah-Zadeh M A, Bates D O, et al. Recombinant human VEGF165b protein is an effective anti-cancer agent in mice[J]. Eur J Cancer, 2008, 44(13):1883-1894. 被引量:1
  • 10Rennel E, Waine E, Harper S, et al. The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice[J]. Br J Cancer, 2008, 98(7):1250-1257. 被引量:1

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部